4519 — Chugai Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Chugai Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	786,946	999,759	1,259,726	1,111,367	1,170,611
Cost of Revenue
Gross Profit	513,481	662,079	783,475	698,717	832,757
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	485,716	577,862	726,417	672,193	628,609
Operating Profit	301,230	421,897	533,309	439,174	542,002
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	298,188	419,385	531,166	443,821	543,034
Provision for Income Taxes
Net Income After Taxes	214,733	302,995	374,429	325,472	387,317
Net Income Before Extraordinary Items
Net Income	214,733	302,995	374,429	325,472	387,317
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	214,733	302,995	374,429	325,472	387,317
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	131	188	228	201	239
Dividends per Share